Google+ Badge

Thursday, June 25, 2015

Cardiovascular Research: Nanoparticle 'wrapper' delivers chemical that stops fatty buildup ♦ Fewer than one in 10 older heart patients get life-saving defibrillators ♦ Uninterrupted vitamin K antagonists recommended during ablation

Nanoparticle 'wrapper' delivers chemical that stops fatty buildup in rodent arteries In what may be a major leap forward in the quest for new treatments of the most common form of cardiovascular disease, scientists report they have found a way to halt and reverse the progression of atherosclerosis in rodents by loading microscopic nanoparticles with a chemical that restores the animals' ability to properly handle cholesterol.
Uninterrupted vitamin K antagonists recommended during ablation, device implantation Experts have recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation. Dramatic changes in the field during the last five years demanded a revision, they say.
Fewer than one in 10 older heart patients get life-saving defibrillators Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a study. But fewer than 1 in 10 eligible patients actually get a defibrillator within a year of their heart attacks,
First ESC recommendations for arrhythmias, chronic kidney disease published Significant interactions occur between the heart and kidney, and even mild kidney disease is associated with an increased risk of cardiovascular disease. Sudden cardiac death is the most common cause of death in dialysis patients including children, accounting for 50% of cardiac deaths and 25% of all deaths.
Uninterrupted NOAC therapy during AF ablation appears safe Uninterrupted treatment with novel oral anticoagulants during catheter ablation of atrial fibrillation is safe, suggests new research. Continuation of NOAC therapy was not associated with periprocedural bleeding or thromboembolic complications.

No comments:

Post a Comment